North America Pharmaceutical Excipients Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Clinical Indication, Functionality, Application, and End User

List of Tables

The North America pharmaceutical excipients market is expected to grow from US$ 3,715.72 million in 2022 to US$ 5,326.59 million by 2028. It is estimated to register a CAGR of 6.2% from 2022 to 2028.

Increasing Product Launches is Fueling the Growth of North America pharmaceutical excipients market

The pharmaceutical excipients market is characterized by the presence of large and small market players. A few product launches have taken place in recent years. For instance, in October 2022, Rouqette, a pharmaceutical and nutraceutical excipients provider, launched two next-generation mannitol products-PEARLITOL CR-H and PEARLITOL 200 GT- for direct compression. These excipients have been specially formulated to overcome the unique drug formulation challenges in the pharmaceutical spaces, which helps the manufacturers optimize direct compression processes and expand into application areas such as mini tabs and controlled-release tablets. Similarly, in March 2022, Lubrizol Life Science Health launched Apisolex, a novel solubility-enhancing excipient for parenteral drug products. With the ability to improve solubility by up to 50,000-fold and support high drug loading, Apisolex excipient provides access to new and improved parenteral drug products. This is especially relevant in oncology, as direct injection of drugs into the bloodstream ensures higher bioavailability and lower patient variability compared to oral delivery. Similarly, in April 2021, DFE Pharma, the pharmaceutical excipient solution provider, launched its new product line, BioHale, a solution for biopharmaceutical manufacturers. With the launch of BioHale Sucrose, DFE Pharma offers exceptional market purity and low endotoxin excipient to be used in the formulation. The active participation of market players in product innovation and development, leading to the increase in product launches, is fueling the growth of the North America pharmaceutical excipients market .

North America Pharmaceutical Excipients Market Overview

The North America pharmaceutical excipients market is segmented into the US, Canada, and Mexico. The US held the largest share of the North American pharmaceutical excipients market in 2021. In North America, economic prosperity and a rise in demand for pharmaceuticals have boosted drug production. Consequently, excipient consumption is a key factor driving a gradual increase in manufacturing expenditures. Within the pharmaceutical industry, the falling price pressure lowered R&D productivity, and stringent regulations have prompted drug manufacturers to progressively turn to produce excipients with the intent to develop differentiated and value-adding products at low prices without compromising quality. The pharmaceutical industry has continuously been one of the most advanced research and development industries in the US. According to the International Trade Administration report in 2016, the research-based industry generally allocates ~15-20% of revenues to R&D activities and invests over US$ 50 billion in R&D annually. The US remains the global leader in innovative R&D investment. Thus, the research activities that fuel new drug manufacturing have a positive impact on the use of pharmaceutical excipients in dosage forms.

North America Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)

North America Pharmaceutical Excipients Market Segmentation

The North America pharmaceutical excipients market is segmented into type, clinical indication, functionality, application, end user, and country.

Based on type, the North America pharmaceutical excipients market is segmented into bioresorbable polymers & lipids & liposome-based formulation, oleochemicals, sugars, cellulose, starches, petrochemicals, plant protein & polyols & cyclodextrins, inorganic chemicals, and others. The inorganic chemicals segment registered the largest market share in 2022.

Based on clinical indication, the North America pharmaceutical excipients market is segmented into cancer, metabolic, infectious diseases, dental, ophthalmic, gene therapies, and others. The cancer segment registered the largest market share in 2022.

Based on functionality, the North America pharmaceutical excipients market is segmented into coloring agent & coating agents, sweetener & flavoring agents, suspending & viscosity agents, preservative & controlled-release, antioxidant & oil, tablet filler & diluents, binders & compression aids & granulating agents, emulsifiers, and others. The tablet filler and diluents segment registered the largest market share in 2022.

Based on application, the North America pharmaceutical excipients market is segmented into parenteral, orals formulations & tablets, capsules, liquid & injectable, physicochemical excipient container interactions in prefilled syringes, nutraceuticals & OTC, topical, and others. The orals formulations & tablets segment registered the largest market share in 2022.

Based on end user, the North America pharmaceutical excipients market is segmented into biopharma industries, pharma industries, animal health, and others. The pharma industries segment registered the largest market share in 2022.

Based on country, the North America pharmaceutical excipients market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022.

Archer-Daniels-Midland Co, AshLand Inc, Avantor Inc, BASF SE, Evonik Industries AG, JRS PHARMA GmbH & Co. KG, MEGGLE GmbH & Co KG, Roquette Freres SA, The Dow Chemical Co, and The Lubrizol Corp are among the leading companies operating in the North America pharmaceutical excipients market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America pharmaceutical excipients market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America pharmaceutical excipients market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the pharmaceutical excipients market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

Product Code: TIPRE00022815

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Pharmaceutical Excipients Market - By Type
- 1.3.2 North America Pharmaceutical Excipients Market - By Clinical Indication
- 1.3.3 North America Pharmaceutical Excipients Market - By Functionality
- 1.3.4 North America Pharmaceutical Excipients Market - By Application
- 1.3.5 North America Pharmaceutical Excipients Market - By End User
- 1.3.6 North America Pharmaceutical Excipients Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Pharmaceutical Excipients Market - Market Landscape

4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion

5. North America Pharmaceutical Excipients Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Growing Generics Market
- 5.1.2 Increasing Product Launches
5.2 Market Restraints
- 5.2.1 Cost and Time-Intensive Drug Development Process
5.3 Market Opportunities
- 5.3.1 Rising Demand and Emphasis on Co-Processed Excipients
5.4 Future Trends
- 5.4.1 Use of Nanotechnology to Improve Excipients Capabilities
5.5 Impact Analysis

6. Pharmaceutical Excipients Market - North America Analysis

6.1 North America Pharmaceutical Excipients Market Revenue Forecast & Analysis

7. North America Pharmaceutical Excipients Market Analysis - By Type

7.1 Overview
7.2 North America Pharmaceutical Excipients Market, By Type, 2021 & 2028 (%)
7.3 Bioresorbable Polymers & Lipids & Liposome-Based Formulation
- 7.3.1 Overview
- 7.3.2 Bioresorbable Polymers & Lipids & Liposome-Based Formulation: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Oleochemicals
- 7.4.1 Overview
- 7.4.2 Oleochemicals: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.4.2.1 Fatty Alcohols
    - 7.4.2.1.1 Overview
    - 7.4.2.1.2 Fatty Alcohols: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.4.2.2 Metal Stearates
    - 7.4.2.2.1 Overview
    - 7.4.2.2.2 Metal Stearates: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.4.2.3 Glycerine
    - 7.4.2.3.1 Overview
    - 7.4.2.3.2 Glycerine: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.4.2.4 Others
    - 7.4.2.4.1 Overview
    - 7.4.2.4.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Sugars
- 7.5.1 Overview
  - 7.5.1.1 Sugars: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.5.1.2 Actual Sugars
    - 7.5.1.2.1 Overview
    - 7.5.1.2.2 Actual Sugars: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.5.1.3 Sugar Alcohols
    - 7.5.1.3.1 Overview
    - 7.5.1.3.2 Sugar Alcohols: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.5.1.4 Artificial Sweeteners
    - 7.5.1.4.1 Overview
    - 7.5.1.4.2 Artificial Sweeteners: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Cellulose
- 7.6.1 Overview
- 7.6.2 Cellulose: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.6.2.1 Microcrystalline Cellulose
    - 7.6.2.1.1 Overview
    - 7.6.2.1.2 Microcrystalline Cellulose: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.6.2.2 Cellulose Ethers
    - 7.6.2.2.1 Overview
    - 7.6.2.2.2 Cellulose Ethers: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.6.2.3 Carboxymethyl Cellulose (CMC) and Croscarmellose Sodium
    - 7.6.2.3.1 Overview
    - 7.6.2.3.2 Carboxymethyl Cellulose (CMC) and Croscarmellose Sodium: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.7 Starches
- 7.7.1 Overview
- 7.7.2 Starches: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.7.2.1 Modified Starch
    - 7.7.2.1.1 Modified Starch: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.7.2.2 Dried Starch
    - 7.7.2.2.1 Dried Starch: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.7.2.3 Converted Starch and Pregelatinized Starch
    - 7.7.2.3.1 Carboxymethyl Cellulose (CMC) and Croscarmellose Sodium: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.8 Petrochemicals
- 7.8.1 Overview
- 7.8.2 Petrochemicals: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.8.2.1 Glycols
    - 7.8.2.1.1 Glycols: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.8.2.2 Povidones
    - 7.8.2.2.1 Povidones: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.8.2.3 Mineral Hydrocarbons
    - 7.8.2.3.1 Mineral Hydrocarbons: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.8.2.4 Others
    - 7.8.2.4.1 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.9 Plant Proteins and Polyols and Cyclodextrins
- 7.9.1 Overview
- 7.9.2 Plant Proteins and Polyols and Cyclodextrins: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.10 Inorganic Chemicals
- 7.10.1 Overview
- 7.10.2 Inorganic Chemicals: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.10.2.1 Magnesium and Calcium Carbonate
    - 7.10.2.1.1 Magnesium and Calcium Carbonate: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.10.2.2 Calcium and Aluminium Phosphate
    - 7.10.2.2.1 Calcium and Aluminium Phosphate: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.10.2.3 Silicon Dioxide
    - 7.10.2.3.1 Silicon Dioxide: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.10.2.4 Titanium Dioxide
    - 7.10.2.4.1 Titanium Dioxide: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.10.2.5 Others
    - 7.10.2.5.1 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.11 Others
- 7.11.1 Overview
- 7.11.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)

8. North America Pharmaceutical Excipients Market Analysis and Forecasts To 2028 - By Clinical Indication

8.1 Overview
8.2 North America Pharmaceutical Excipient Market, By Clinical Indication, 2021 & 2028 (%)
8.3 Cancer
- 8.3.1 Overview
- 8.3.2 Cancer: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
8.4 Metabolic
- 8.4.1 Overview
- 8.4.2 Metabolic: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
8.5 Infectious Disease
- 8.5.1 Overview
- 8.5.2 Infectious Disease: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
8.6 Dental
- 8.6.1 Overview
- 8.6.2 Dental: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
8.7 Ophthalmic
- 8.7.1 Overview
- 8.7.2 Ophthalmic: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
8.8 Gene Therapies
- 8.8.1 Overview
- 8.8.2 Gene Therapies: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
8.9 Others
- 8.9.1 Overview
- 8.9.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)

9. North America Pharmaceutical Excipients Market Analysis and Forecasts To 2028 - By Functionality

9.1 Overview
9.2 North America Pharmaceutical Excipient Market, By Functionality, 2021 & 2028 (%)
9.3 Colouring Agents and Coating Agents
- 9.3.1 Overview
- 9.3.2 Colouring Agents and Coating Agents: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.4 Sweetener and Flavouring Agents
- 9.4.1 Overview
- 9.4.2 Sweetener and Flavouring Agents: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.5 Suspending and Viscosity Agents
- 9.5.1 Overview
- 9.5.2 Suspending and Viscosity Agents: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.6 Preservative and Controlled Release
- 9.6.1 Overview
- 9.6.2 Preservative and Controlled Release: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.7 Antioxidant and Oil
- 9.7.1 Overview
- 9.7.2 Antioxidant and Oil: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.8 Tablet Filler and Diluents
- 9.8.1 Overview
- 9.8.2 Tablet Filler and Diluents: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.9 Binders and Compression and Granulating Agents
- 9.9.1 Overview
- 9.9.2 Binders and Compression and Granulating Agents: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.10 Emulsifiers
- 9.10.1 Overview
- 9.10.2 Emulsifiers: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.11 Others
- 9.11.1 Overview
- 9.11.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)

10. North America Pharmaceutical Excipients Market Analysis and Forecasts To 2028 - By Application

10.1 Overview
10.2 North America Pharmaceutical Excipient Market, By Application, 2021 & 2028 (%)
10.3 Parenteral
- 10.3.1 Overview
- 10.3.2 Parenteral: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
10.4 Oral Formulations & Tablets
- 10.4.1 Overview
- 10.4.2 Oral Formulations & Tablets: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
10.5 Capsules
- 10.5.1 Overview
- 10.5.2 Capsules: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 10.5.3 Hard Gels
  - 10.5.3.1 Overview
  - 10.5.3.2 Hard Gels: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 10.5.4 Soft Gels
  - 10.5.4.1 Overview
  - 10.5.4.2 Soft Gels: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
10.6 Liquid & Injectable
- 10.6.1 Overview
- 10.6.2 Liquid & Injectable: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
10.7 Physiochemical Excipient-Container Interactions in Prefilled Syringes
- 10.7.1 Overview
- 10.7.2 Physiochemical Excipient-Container Interactions in Prefilled Syringes: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
10.8 Nutraceutical & OTC
- 10.8.1 Overview
- 10.8.2 Nutraceutical & OTC: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
10.9 Topical
- 10.9.1 Overview
- 10.9.2 Topical: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
10.10 Others
- 10.10.1 Overview
- 10.10.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)

11. North America Pharmaceutical Excipients Market Analysis and Forecasts To 2028 - By End User

11.1 Overview
11.2 North America Pharmaceutical Excipient Market, By End User, 2021 & 2028 (%)
11.3 Biopharma Industries
- 11.3.1 Overview
- 11.3.2 Biopharma Industries: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
11.4 Pharma Industries
- 11.4.1 Overview
- 11.4.2 Pharma Industries: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
11.5 Animal Health
- 11.5.1 Overview
- 11.5.2 Animal Health: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
11.6 Others
- 11.6.1 Overview
- 11.6.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)

12. North America Pharmaceutical Excipients Market Revenue and Forecasts to 2028 - Country Analysis

12.1 Overview
- 12.1.2 North America: Pharmaceutical Excipients Market, by Country, 2021 & 2028 (%)
  - 12.1.2.1 US: Pharmaceutical Excipients Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.1.1 Overview
    - 12.1.2.1.2 US: Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.1.3 US: Pharmaceutical Excipients Market, by Type, 2019-2028
    - 12.1.2.1.3.1 US: Pharmaceutical Excipients Market, by Oleochemicals, 2019-2028
    - 12.1.2.1.3.2 US: Pharmaceutical Excipients Market, by Sugars, 2019-2028
    - 12.1.2.1.3.3 US: Pharmaceutical Excipients Market, by Cellulose, 2019-2028
    - 12.1.2.1.3.4 US: Pharmaceutical Excipients Market, by Starches, 2019-2028
    - 12.1.2.1.3.5 US: Pharmaceutical Excipients Market, by Petrochemicals, 2019-2028
    - 12.1.2.1.3.6 US: Pharmaceutical Excipients Market, by Inorganic Chemicals, 2019-2028
    - 12.1.2.1.4 US: Pharmaceutical Excipients Market, by Clinical Indication, 2019-2028
    - 12.1.2.1.5 US: Pharmaceutical Excipients Market, by Functionality, 2019-2028
    - 12.1.2.1.6 US: Pharmaceutical Excipients Market, by Application, 2019-2028
    - 12.1.2.1.6.1 US: Pharmaceutical Excipients Market, by Capsules, 2019-2028
    - 12.1.2.1.7 US: Pharmaceutical Excipients Market, by End User, 2019-2028
  - 12.1.2.2 Canada: Pharmaceutical Excipients Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.2.1 Overview
    - 12.1.2.2.2 Canada: Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.2.3 Canada: Pharmaceutical Excipients Market, by Type, 2019-2028
    - 12.1.2.2.3.1 Canada: Pharmaceutical Excipients Market, by Oleochemicals, 2019-2028
    - 12.1.2.2.3.2 Canada: Pharmaceutical Excipients Market, by Sugars, 2019-2028
    - 12.1.2.2.3.3 Canada: Pharmaceutical Excipients Market, by Cellulose, 2019-2028
    - 12.1.2.2.3.4 Canada: Pharmaceutical Excipients Market, by Starches, 2019-2028
    - 12.1.2.2.3.5 Canada: Pharmaceutical Excipients Market, by Petrochemicals, 2019-2028
    - 12.1.2.2.3.6 Canada: Pharmaceutical Excipients Market, by Inorganic Chemicals, 2019-2028
    - 12.1.2.2.4 Canada: Pharmaceutical Excipients Market, by Clinical Indication, 2019-2028
    - 12.1.2.2.5 Canada: Pharmaceutical Excipients Market, by Functionality, 2019-2028
    - 12.1.2.2.6 Canada: Pharmaceutical Excipients Market, by Application, 2019-2028
    - 12.1.2.2.6.1 Canada: Pharmaceutical Excipients Market, by Capsules, 2019-2028
    - 12.1.2.2.7 Canada: Pharmaceutical Excipients Market, by End User, 2019-2028
  - 12.1.2.3 Mexico: Pharmaceutical Excipients Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.3.1 Overview
    - 12.1.2.3.2 Mexico: Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.3.3 Mexico: Pharmaceutical Excipients Market, by Type, 2019-2028
    - 12.1.2.3.3.1 Mexico: Pharmaceutical Excipients Market, by Oleochemicals, 2019-2028
    - 12.1.2.3.3.2 Mexico: Pharmaceutical Excipients Market, by Sugars, 2019-2028
    - 12.1.2.3.3.3 Mexico: Pharmaceutical Excipients Market, by Cellulose, 2019-2028
    - 12.1.2.3.3.4 Mexico: Pharmaceutical Excipients Market, by Starches, 2019-2028
    - 12.1.2.3.3.5 Mexico: Pharmaceutical Excipients Market, by Petrochemicals, 2019-2028
    - 12.1.2.3.3.6 Mexico: Pharmaceutical Excipients Market, by Inorganic Chemicals, 2019-2028
    - 12.1.2.3.4 Mexico: Pharmaceutical Excipients Market, by Clinical Indication, 2019-2028
    - 12.1.2.3.5 Mexico: Pharmaceutical Excipients Market, by Functionality, 2019-2028
    - 12.1.2.3.6 Mexico: Pharmaceutical Excipients Market, by Application, 2019-2028
    - 12.1.2.3.6.1 Mexico: Pharmaceutical Excipients Market, by Capsules, 2019-2028
    - 12.1.2.3.7 Mexico: Pharmaceutical Excipients Market, by End User, 2019-2028

13. North America Pharmaceutical Excipients Market-Industry Landscape

13.1 Overview
13.2 Organic Developments
- 13.2.1 Overview
13.3 Inorganic Developments
- 13.3.1 Overview

14. Company Profile

14.1 JRS PHARMA GmbH & Co. KG
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Roquette Freres SA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 BASF SE
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Evonik Industries AG
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 AshLand Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Archer-Daniels-Midland Co
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 The Dow Chemical Co
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 The Lubrizol Corp
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Avantor Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 MEGGLE GmbH & Co KG
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms